Balance Sheet Details (Tables)

9 Months Ended

Sep. 30, 2021

Balance Sheet Related Disclosures [Abstract]

Schedule of inventory

The following table provides details of our inventory balance:

(In thousands)	September 30, 2021		December 31, 2020
Raw materials	$	1,011	$	391
Work in process	1,299		243
Finished goods	1,192		392
Total	$	3,502	$	1,026

Details of accrued and other current liabilities

The following table provides details of accrued and other current liabilities:

(In thousands)	September 30, 2021		December 31, 2020
Accrued clinical trial expenses	$	13,272	$	16,477
Accrued compensation	12,243		10,917
Accrued milestone payment	—		15,000
Other accrued liabilities	20,596		12,570
Total	$	46,111	$	54,964